I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 13 studies | 33% ± 15% | |
| epithelial cell | 10 studies | 30% ± 13% | |
| fibroblast | 9 studies | 25% ± 8% | |
| smooth muscle cell | 9 studies | 22% ± 8% | |
| myofibroblast cell | 7 studies | 20% ± 4% | |
| basal cell | 7 studies | 26% ± 14% | |
| plasmacytoid dendritic cell | 7 studies | 21% ± 5% | |
| CD4-positive, alpha-beta T cell | 6 studies | 26% ± 11% | |
| connective tissue cell | 6 studies | 25% ± 7% | |
| pericyte | 6 studies | 23% ± 7% | |
| CD8-positive, alpha-beta T cell | 6 studies | 23% ± 8% | |
| progenitor cell | 5 studies | 20% ± 2% | |
| erythroblast | 5 studies | 32% ± 14% | |
| abnormal cell | 5 studies | 27% ± 10% | |
| hematopoietic precursor cell | 4 studies | 31% ± 14% | |
| mesothelial cell | 4 studies | 39% ± 13% | |
| endothelial cell | 4 studies | 23% ± 11% | |
| natural killer cell | 4 studies | 24% ± 5% | |
| deuterosomal cell | 3 studies | 20% ± 4% | |
| B cell | 3 studies | 23% ± 7% | |
| neural crest cell | 3 studies | 25% ± 1% | |
| dendritic cell | 3 studies | 30% ± 7% | |
| enteroendocrine cell | 3 studies | 26% ± 11% | |
| goblet cell | 3 studies | 26% ± 8% | |
| intestinal crypt stem cell | 3 studies | 23% ± 2% | |
| erythrocyte | 3 studies | 39% ± 14% | |
| transit amplifying cell | 3 studies | 26% ± 8% | |
| hematopoietic stem cell | 3 studies | 18% ± 3% |
